200 related articles for article (PubMed ID: 34898155)
1. Topical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines.
Desai S; Hartman C; Grimes P; Shah S
J Drugs Dermatol; 2021 Dec; 20(12):1276-1279. PubMed ID: 34898155
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of solar lentigines by topical application of stabilized cysteamine: A vehicle-controlled, double-blind randomized study.
Saki N; Modabber V; Kasraei H; Kasraee B
Health Sci Rep; 2024 Feb; 7(2):e1930. PubMed ID: 38410492
[TBL] [Abstract][Full Text] [Related]
3. Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula.
Kasraee B; Mansouri P; Farshi S
J Cosmet Dermatol; 2019 Feb; 18(1):293-295. PubMed ID: 30537063
[TBL] [Abstract][Full Text] [Related]
4. Comparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin Unevenness.
Callender VD; Orlinsky D; Simmons-O'Brien E; Nwade NC; Rhodes T; Byrd AS
J Drugs Dermatol; 2024 Jan; 23(1):1260-1265. PubMed ID: 38206158
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study.
Karrabi M; Mansournia MA; Sharestanaki E; Abdollahnejad Y; Sahebkar M
Arch Dermatol Res; 2021 Sep; 313(7):539-547. PubMed ID: 32879998
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
Lima PB; Dias JAF; Cassiano D; Esposito ACC; Bagatin E; Miot LDB; Miot HA
Int J Dermatol; 2020 Dec; 59(12):1531-1536. PubMed ID: 32864760
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
[TBL] [Abstract][Full Text] [Related]
8. Topical Treatments for Melasma and Post-inflammatory Hyperpigmentation.
Sadick N; Pannu S; Abidi Z; Arruda S
J Drugs Dermatol; 2023 Nov; 22(11):1118-1123. PubMed ID: 37943277
[TBL] [Abstract][Full Text] [Related]
9. A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids).
Mathe N; Balogun M; Yoo J
J Cosmet Dermatol; 2021 Jan; 20(1):204-206. PubMed ID: 32997864
[TBL] [Abstract][Full Text] [Related]
10. Cysteamine Isobionic-Amide Complex Versus Kligman's Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action.
Sachdev M; Grimes PE; Callender V; Hartman CL; Taylor SC; Elbuluk N; Badawi A; Funasaka Y; Lim J; Ng CY; Desai SR
J Drugs Dermatol; 2024 Feb; 23(2):9-16. PubMed ID: 38306138
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
Farshi S; Mansouri P; Kasraee B
J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
[TBL] [Abstract][Full Text] [Related]
12. Combination of 5% cysteamine and 4% nicotinamide in melasma: Efficacy, tolerability, and safety.
Crocco EI; Torloni L; Fernandes PB; de Campos MEBB; Gonzaga M; Silva FC; Nasario JPS; Guerra LO; Csipak AR; Castilho VC
J Cosmet Dermatol; 2024 May; 23(5):1703-1712. PubMed ID: 38327114
[TBL] [Abstract][Full Text] [Related]
13. Is cysteamine use effective in the treatment of melasma? A systematic review and meta-analysis.
Dos Santos-Neto AG; da Silva ÍCV; Melo CR; Santana AAM; de Albuquerque-Junior RLC
Dermatol Ther; 2022 Dec; 35(12):e15961. PubMed ID: 36285354
[TBL] [Abstract][Full Text] [Related]
14. Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials.
Austin E; Nguyen JK; Jagdeo J
J Drugs Dermatol; 2019 Nov; 18(11):. PubMed ID: 31741361
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
Mansouri P; Farshi S; Hashemi Z; Kasraee B
Br J Dermatol; 2015 Jul; 173(1):209-17. PubMed ID: 25251767
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review.
Ahramiyanpour N; Saki N; Akbari Z; Shamsi-Meymandi S; Amiri R; Heiran A
J Cosmet Dermatol; 2021 Nov; 20(11):3593-3602. PubMed ID: 34591360
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cysteamine and methimazole in treating melasma: A comparative narrative review.
Niazi S; Gheisari M; Moravvej H; Doroodgar F; Niazi F
J Cosmet Dermatol; 2022 Sep; 21(9):3867-3875. PubMed ID: 35751542
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Effectiveness of Stabilized Cysteamine 5% Cream Compared to Hydroquinone 4%/Ascorbic Acid 3% Combination Cream in Treating Acne-induced Post-inflammatory Hyperpigmentation: A Randomized, Controlled Study.
Ahmadi K; Miri A; Bizaval Z; Sepaskhah M; Ranjbar S; Bagheri Z; Kasraee B
J Clin Aesthet Dermatol; 2024 Apr; 17(4):37-41. PubMed ID: 38638185
[TBL] [Abstract][Full Text] [Related]
19. [Chemical peeling for treatment of Melasma, pigmentary disorders and hyperpigmentation : Indications, effectivity and risks].
Borelli C; Fischer S
Hautarzt; 2020 Dec; 71(12):950-959. PubMed ID: 33141276
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
